e-learning
resources
London 2016
Sunday, 04.09.2016
Sarcoidosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence and prognostic factors for airflow obstruction in sarcoidosis
Michał Bednarek (Warszawa, Poland), Michal Bednarek, Anna Goljan-Geremek, Elzbieta Puscinska, Adam Nowinski, Damian Korzybski, Pawel Sliwinski
Source:
International Congress 2016 – Sarcoidosis
Session:
Sarcoidosis
Session type:
Thematic Poster
Number:
824
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Michał Bednarek (Warszawa, Poland), Michal Bednarek, Anna Goljan-Geremek, Elzbieta Puscinska, Adam Nowinski, Damian Korzybski, Pawel Sliwinski. Incidence and prognostic factors for airflow obstruction in sarcoidosis. Eur Respir J 2016; 48: Suppl. 60, 824
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Airway obstruction in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Consequences of different definitions of airway obstruction
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Reversibility of airway obstruction in sarcoidosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 276s
Year: 2003
Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Characteristics of patients with persistent airflow obstruction from an asthma clinic
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
What defines airflow obstruction in asthma?
Source: Eur Respir J 2009; 34: 568
Year: 2009
Sarcoidosis and airway obstruction
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Long-term outcome in non-reversible and reversible airway obstruction
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
The effects of bronchodilators in patients with tuberculosis-destroyed lung and chronic airflow obstruction
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Non-invasive evaluation of airway inflammation in non-CF bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Precision of bronchoprovocation testing in the diagnosis of exercise-induced laryngeal obstruction
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Pulmonary function and sinonasal symptoms in asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 845s
Year: 2006
Pseudo hyperinflation of lung in patients with achalasia
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
The outcome of broncho-dilation among subjects with airway obstruction in the general population
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept